3. Introduction
âȘ Joseph Priestley, who discovered oxygen in 1774,
suggested that it might be âpeculiarly salutary to
the lungs in certain morbid casesâ
âȘ Administration of oxygen at concentrations
greater than that in room air to treat or prevent
hypoxemia
4. O2 therapy: recommendations
âȘ Cardiac and respiratory arrest
âȘ Hypoxemia (PaO2 < 60 mm Hg, SaO2 < 90%)
âȘ Hypotension (systolic BP < 100 mm Hg)
âȘ Low cardiac output and metabolic acidosis
âȘ Respiratory distress (respiratory rate > 24/min)
6. Classification
Performance of the device
âȘ Fixed (venturi mask)
âȘ Variable performance (nasal prong, face mask)
Flows delivered by the device
âȘ Low flow (nasal prongs, face mask)
âȘ High flow (venturi mask)
7. Patient dependency
âȘ Dependent (face mask, nasal prongs, CPAP device)
âȘ Patient-independent (Ventilators)
Degree of dependency
âȘ Low dependency (face mask, nasal prongs)
âȘ Medium dependency (CPAP mask and equipment)
âȘ High dependency (noninvasive or invasive positive
pressure ventilation)
8. Low flow O2 delivery system
Nasal cannula
âȘ Low flow variable performance device with no capacity
âȘ Patientâs nasopharynx: anatomic reservoir
âȘ During inspiration, oxygen diluted with room air
âȘ FiO2 depends on flow rate of oxygen, patientâs minute ventilation and
inspiratory flow and volume of the nasopharynx
Flow
âȘ 1 L/m: 24% 2 L/m: 28% 3 L/m: 32%
âȘ 4 L/m: 36% 5 L/m: 40%
9. Advantages Disadvantages
âȘ Comfortable for patient
âȘ Ideal for claustrophobic patients
âȘ Ideal for oxygen dependent
patients requiring small amounts
of oxygen esp at home
âȘ Humidification not required up to
4 L/m
âȘ Unpredictable FiO2
âȘ Maximum estimated FiO2 0.4
âȘ Not appropriate in respiratory
distress
âȘ High flow: drying and irritating
effect on nasal mucosa
âȘ Use may be limited by presence of
excessive mucus, mucosal edema,
or a deviated septum
10. Face mask
âȘ Low flow variable performance device with small capacity
âȘ Pediatric face masks (70â100 mL), adult (100â250 mL)
âȘ Higher FiO2 âdelivered if mask volume increased
âȘ O2 that gets collected in the apparatus dead space at the
end of expiration is inhaled at the beginning of the next
breath
âȘ Exhaled gases vented out through holes on each side of the
mask, which also serve as room-air entrainment ports.
11. Flow
âȘ 5-6 L/m: 40% 6-7 L/m: 50% 7-8 L/m: 60%
Advantages
âȘ Quick and easy to setup and apply
Disadvantages
âȘ Unpredictable FiO2
âȘ Not more than 0.5 FiO2 can be delivered
âȘ CO2 rebreathing with flow rates <2 L/m
12. Reservoir Face mask
âȘ High capacity, low-flow, variable performance
device
âȘ Higher FiO2 due to reservoir bag attached
âȘ O2 flows directly into reservoir bag
âȘ Flow rate of O2 adjusted so that bag remains
completely/ partially distended
13. Partial rebreathing mask
âȘ Simple mask with a reservoir bag
âȘ Oxygen flow should be supplied to
maintain reservoir bag at least 1/3 to 1/2
full on inspiration
âȘ Reservoir receives fresh gas plus exhaled
gas approximately equal to the volume of
the patientâs anatomic dead space
âȘ Exhaled gases combine with fresh O2
âȘ At a flow of 6â10 L/min â40â70% oxygen
14. Non-rebreathing masks
âȘ Do not permit mixing of exhaled gases with fresh
gas
âȘ One-way valve over reservoir bagâ prevents entry
of expired gas
âȘ One-way valve over one of the side ports limits
entrainment of room air during inspiration
âȘ Higher FiO2 than simple, partial-rebreathing masks
âȘ FiO275â90% at flow rates of 12â15 L/m
15. Venturi mask
âȘ Venturi effect based on Bernoulli principle
âȘ As the velocity of a fluid â, pressure exerted â
âȘ When a fluid flows through a constriction the fluid
velocity must increase to satisfy the equation of
continuity
âȘ Describes how a second fluid can be entrained into the
stream of the first
17. âȘ High-flow, fixed performance device
âȘ O2 supplied to mask through narrow bore oxygen tubing
âȘ A negative pressure createdâroom air entrained through
the apertures in the Venturi barrel
âȘ Resultant air-oxygen mixture containing the prescribed O2
concentration flows into face piece for patient breathing
âȘ Excess gas flushes out the expired CO2 through the holes on
the sides of the mask âNo rebreathing
18. FiO2 provided
by the Venturi
valve
O2 flow to
the valve
(L/min)
Amount of
air entrained
(L/min)
Total flow to
patient
(L/min)
0.24 2 51 53
0.28 4 41 45
0.31 6 41 47
0.35 8 37 45
0.40 10 32 42
0.60 15 15 30
19. Medium dependency system: CPAP
âȘ Used when respiratory assistance with O2 supplementation
needed
âȘ Can only be used in spontaneously breathing patients
âȘ CPAP mask: Face mask with head strap, O2-CPAP valve,
flow generator and wide bore tubings
âȘ O2-CPAP valves provide CPAP from 2.5â20 cm of H2O
âȘ Flow generator can be plugged into wall outlet for O2
âȘ Wide bore tubing connects the flow generator to the mask
âȘ 2 one way valves: inlet valve and outlet valve
20. Enclosure systems
âȘ Oxygen hood: Transparent enclosure, surrounds head of neonate/
small infant
âȘ Well-tolerated, and allow easy access to chest, trunk, and extremities
âȘ Continuous flow of humidified O2 is supplied to the hood
âȘ Deliver 80â90% oxygen at a flow rate of 10â15 L/m
âȘ Limitation
âȘ Size: Children <1 year of age
âȘ Decrease in O2 concentration when enclosure is opened
âȘ Risk for cutaneous fungal infection (humidified O2)
âȘ Use of an improperly sized hoodâskin irritation
âȘ Hypoxia or hypercapnia from inadequate or loss of gas flow
21. High-flow nasal cannula
âȘ High-flow nasal O2 using heated and
humidified gas
âȘ Heated to body temperature and
supersaturated with water (to a relative
humidity of 99%)
âȘ O2 flow rates up to 40â60 L/min
âȘ Wide nasal prongs without discomfort and
mucosal injury
âȘ Improved oxygenation and gas exchange
âȘ Avoiding intubation and mechanical
ventilation
22. Toxic nature of Oxygen
Hydrogen
peroxide
Super-
oxide
Hydroxyl
Radical
Hypochlorous
Acid
Singlet
Oxygen
O2 Metabolism
23. Safe FiO2
Pulmonary oxygen toxicity
âȘ Inflammatory lung injury in patients who have inhaled
gas with an FiO2 >60% for longer than 48 hours
âȘ If antioxidant stores in lungs depleted, O2 toxicity
expected at FiO2 <60%
âȘ FiO2 above 21% can represent toxic exposure to
oxygen in critically ill patients
âȘ Best practice: FiO2 to the lowest tolerable level